Back

Q&A and closing remarks.

30 April 2017 (13:50 - 14:00)
Organised by:
Congress Presentation Part of: Management of co-morbidities in heart failure - Exploring new frontiers Miscellaneous HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Martin Cowie

London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Introduction & remarks.
Professor N. Danchin (Paris, FR)
Presentation thumbnail
Expanding the evidence for rivaroxaban in Atrial Fibrillation (AF) patients with comorbidites including Heart Failure (HF): from Randomized Controlled Trials (RCT) to Real World Evidence (RWE).
Professor M. Cowie (London, GB)
Presentation thumbnail
Options in thrombosis prevention and vascular health – What’s on the horizon?
Professor K. Fox (Edinburgh, GB)
Presentation thumbnail
Broadening the evidence base for rivaroxaban in heart failure.
Professor B. Greenberg (La Jolla, US)
Presentation thumbnail
Exploring new frontiers: is it time for a comorbidity-based approach in heart failure?
Doctor R. Mentz (Durham, US)

Access the full session

Session thumbnail
Management of co-morbidities in heart failure - Exploring new frontiers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 13:50 CET
You may be interested in
thumbnail
Congress Presentation
Questions & answers.
4 April 2022
thumbnail
Congress Presentation
Conclusion
30 August 2025
thumbnail
Congress Presentation
Q&A and meeting close
27 August 2023
thumbnail
Congress Presentation
Structural heart disease in the transcatheter era: what the ESC/EACTS 2025 Guidelines mean for today’s practice - conclusion
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources